Independent Financial Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Independent Financial Group's BIIB Position: Q2 2026 in Review
Independent Financial Group increased its Biogen (BIIB) stake by 3.2% in Q2 2026, buying an estimated $31.8K and bringing the position to 5,364 shares worth $1.16M. The position accounts for 0.02% of the portfolio, ranked #629.
Independent Financial Group first reported a position in BIIB in Q2 2021 and has held it in 18 quarters since. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Independent Financial Group held 5,364 shares of Biogen worth $1.16M as of Q2 2026.
- Independent Financial Group bought 166 Biogen shares in Q2 2026, an estimated $31.8K.
- Biogen made up 0.02% of Independent Financial Group's portfolio in Q2 2026, its #629 holding.
- Independent Financial Group first reported a position in Biogen in Q2 2021 and has held it in 18 quarters since.
- 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Independent Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.